HIGHLIGHTS
- who: Changqing Li from the Macau University of Science and Technology, Macao SAR, China have published the Article: Molecular mechanism of Epimedium in the treatment of vascular dementia based on network pharmacology and molecular docking, in the Journal: (JOURNAL)
- what: The authors investigated the potential mechanisms of Epimedium for the treatment of VaD through network pharmacology, molecular docking approach, and experimental validation to reveal the active ingredients of Epimedium and their respective mechanisms. This study showed that Epimedium inhibited the activation of TNF and MAPK/ERK pathways. As the study showed, Epimedium may regulate the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.